MedPath

Ammonia

These highlights do not include all the information needed to use Ammonia N 13 Injection safely and effectively. See full prescribing information for Ammonia N 13 Injection. Ammonia N 13 Injection for intravenous use Initial U.S. Approval: 2007

Approved
Approval ID

85882893-0661-46c2-a5f2-a73f6ea4fb5a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 8, 2020

Manufacturers
FDA

SOFIE Co. dba SOFIE

DUNS: 957704737

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

AMMONIA N-13

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49609-003
Application NumberANDA203543
Product Classification
M
Marketing Category
C73584
G
Generic Name
AMMONIA N-13
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 8, 2020
FDA Product Classification

INGREDIENTS (2)

SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
AMMONIA N-13Active
Quantity: 260 mCi in 1 mL
Code: 9OQO0E343Z
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ammonia - FDA Drug Approval Details